Annual Shareholders Equity
$5.98 B
+$1.19 B+24.77%
31 December 2023
Summary:
United Therapeutics annual stockholders equity is currently $5.98 billion, with the most recent change of +$1.19 billion (+24.77%) on 31 December 2023. During the last 3 years, it has risen by +$2.03 billion (+51.17%). UTHR annual shareholders equity is now at all-time high.UTHR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$6.10 B
+$403.70 M+7.09%
30 September 2024
Summary:
United Therapeutics quarterly stockholders equity is currently $6.10 billion, with the most recent change of +$403.70 million (+7.09%) on 30 September 2024. Over the past year, it has increased by +$116.10 million (+1.94%). UTHR quarterly shareholders equity is now at all-time high.UTHR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +1.9% |
| 3 y3 years | +51.2% | +54.1% |
| 5 y5 years | +115.3% | +119.4% |
UTHR Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +51.2% | at high | +54.1% |
| 5 y | 5 years | at high | +115.3% | at high | +119.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
United Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.10 B(+7.1%) |
| June 2024 | - | $5.70 B(+6.7%) |
| Mar 2024 | - | $5.34 B(-10.8%) |
| Dec 2023 | $5.98 B(+24.8%) | $5.98 B(+4.8%) |
| Sept 2023 | - | $5.71 B(+5.6%) |
| June 2023 | - | $5.41 B(+5.6%) |
| Mar 2023 | - | $5.12 B(+6.8%) |
| Dec 2022 | $4.80 B(+21.2%) | $4.80 B(+5.1%) |
| Sept 2022 | - | $4.56 B(+5.6%) |
| June 2022 | - | $4.32 B(+3.4%) |
| Mar 2022 | - | $4.18 B(+5.5%) |
| Dec 2021 | $3.96 B(+16.6%) | $3.96 B(+3.4%) |
| Sept 2021 | - | $3.83 B(+5.2%) |
| June 2021 | - | $3.64 B(+5.6%) |
| Mar 2021 | - | $3.45 B(+1.5%) |
| Dec 2020 | $3.40 B(+22.1%) | $3.40 B(+3.4%) |
| Sept 2020 | - | $3.28 B(+6.1%) |
| June 2020 | - | $3.09 B(+4.9%) |
| Mar 2020 | - | $2.95 B(+6.0%) |
| Dec 2019 | $2.78 B(-1.0%) | $2.78 B(+2.4%) |
| Sept 2019 | - | $2.72 B(+5.8%) |
| June 2019 | - | $2.57 B(+9.8%) |
| Mar 2019 | - | $2.34 B(-16.7%) |
| Dec 2018 | $2.81 B(+32.4%) | $2.81 B(+3.5%) |
| Sept 2018 | - | $2.71 B(+4.9%) |
| June 2018 | - | $2.58 B(+8.2%) |
| Mar 2018 | - | $2.39 B(+12.6%) |
| Dec 2017 | $2.12 B(+13.9%) | $2.12 B(+1.5%) |
| Sept 2017 | - | $2.09 B(+16.4%) |
| June 2017 | - | $1.80 B(-13.5%) |
| Mar 2017 | - | $2.08 B(+11.5%) |
| Dec 2016 | $1.86 B(+16.4%) | $1.86 B(+0.7%) |
| Sept 2016 | - | $1.85 B(+1.8%) |
| June 2016 | - | $1.82 B(+5.5%) |
| Mar 2016 | - | $1.72 B(+7.7%) |
| Dec 2015 | $1.60 B(+26.4%) | $1.60 B(+8.1%) |
| Sept 2015 | - | $1.48 B(+40.4%) |
| June 2015 | - | $1.05 B(-5.3%) |
| Mar 2015 | - | $1.11 B(-12.1%) |
| Dec 2014 | $1.27 B(-3.0%) | $1.27 B(+4.0%) |
| Sept 2014 | - | $1.22 B(+0.3%) |
| June 2014 | - | $1.21 B(-10.7%) |
| Mar 2014 | - | $1.36 B(+4.1%) |
| Dec 2013 | $1.30 B(+19.1%) | $1.30 B(-0.3%) |
| Sept 2013 | - | $1.31 B(+7.6%) |
| June 2013 | - | $1.22 B(+4.7%) |
| Mar 2013 | - | $1.16 B(+6.1%) |
| Dec 2012 | $1.09 B(+14.1%) | $1.09 B(+3.2%) |
| Sept 2012 | - | $1.06 B(+5.1%) |
| June 2012 | - | $1.01 B(-1.5%) |
| Mar 2012 | - | $1.02 B(+6.8%) |
| Dec 2011 | $959.37 M | $959.37 M(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $1.08 B(+8.2%) |
| June 2011 | - | $1.00 B(+8.5%) |
| Mar 2011 | - | $924.21 M(+4.6%) |
| Dec 2010 | $883.89 M(+35.4%) | $883.89 M(+5.1%) |
| Sept 2010 | - | $840.73 M(+7.5%) |
| June 2010 | - | $782.30 M(+7.4%) |
| Mar 2010 | - | $728.25 M(+11.5%) |
| Dec 2009 | $653.01 M(+17.6%) | $653.01 M(+2.1%) |
| Sept 2009 | - | $639.56 M(+5.7%) |
| June 2009 | - | $604.98 M(+4.8%) |
| Mar 2009 | - | $577.28 M(+4.0%) |
| Dec 2008 | $555.33 M(+87.7%) | $555.33 M(+32.7%) |
| Sept 2008 | - | $418.59 M(+15.2%) |
| June 2008 | - | $363.41 M(+11.3%) |
| Mar 2008 | - | $326.43 M(+10.4%) |
| Dec 2007 | $295.79 M(+44.6%) | $295.79 M(+40.5%) |
| Sept 2007 | - | $210.54 M(+17.6%) |
| June 2007 | - | $179.00 M(+10.3%) |
| Mar 2007 | - | $162.35 M(-20.7%) |
| Dec 2006 | $204.61 M(-25.6%) | $204.61 M(-25.6%) |
| Sept 2006 | - | $275.05 M(-8.2%) |
| June 2006 | - | $299.52 M(+5.0%) |
| Mar 2006 | - | $285.29 M(+3.7%) |
| Dec 2005 | $275.10 M(+43.6%) | $275.10 M(+15.4%) |
| Sept 2005 | - | $238.36 M(+9.9%) |
| June 2005 | - | $216.80 M(+6.6%) |
| Mar 2005 | - | $203.31 M(+6.1%) |
| Dec 2004 | $191.64 M(+14.2%) | $191.64 M(+6.9%) |
| Sept 2004 | - | $179.34 M(+5.1%) |
| June 2004 | - | $170.59 M(+3.4%) |
| Mar 2004 | - | $165.05 M(-1.6%) |
| Dec 2003 | $167.76 M(-2.3%) | $167.76 M(-1.1%) |
| Sept 2003 | - | $169.55 M(+0.0%) |
| June 2003 | - | $169.47 M(+0.7%) |
| Mar 2003 | - | $168.31 M(-1.9%) |
| Dec 2002 | $171.66 M(-12.6%) | $171.66 M(-1.4%) |
| Sept 2002 | - | $174.11 M(-6.4%) |
| June 2002 | - | $186.04 M(-2.5%) |
| Mar 2002 | - | $190.80 M(-2.8%) |
| Dec 2001 | $196.40 M(-16.3%) | $196.40 M(-3.5%) |
| Sept 2001 | - | $203.57 M(-4.7%) |
| June 2001 | - | $213.59 M(-5.0%) |
| Mar 2001 | - | $224.79 M(-4.2%) |
| Dec 2000 | $234.74 M(+337.9%) | $234.74 M(-3.3%) |
| Sept 2000 | - | $242.77 M(+111.5%) |
| June 2000 | - | $114.81 M(-7.1%) |
| Mar 2000 | - | $123.58 M(+130.6%) |
| Dec 1999 | $53.60 M(+221.0%) | $53.60 M(-9.8%) |
| Sept 1999 | - | $59.40 M(+1.9%) |
| June 1999 | - | $58.30 M(+276.1%) |
| Mar 1999 | - | $15.50 M |
| Dec 1998 | $16.70 M | - |
FAQ
- What is United Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for United Therapeutics?
- What is United Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for United Therapeutics?
- What is United Therapeutics quarterly shareholders equity year-on-year change?
What is United Therapeutics annual stockholders equity?
The current annual shareholders equity of UTHR is $5.98 B
What is the all time high annual shareholders equity for United Therapeutics?
United Therapeutics all-time high annual stockholders equity is $5.98 B
What is United Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of UTHR is $6.10 B
What is the all time high quarterly shareholders equity for United Therapeutics?
United Therapeutics all-time high quarterly stockholders equity is $6.10 B
What is United Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, UTHR quarterly stockholders equity has changed by +$116.10 M (+1.94%)